PARL

Presenilin-associated rhomboid-like protein, mitochondrial · Q9H300 · PARL on Sugi Atlas →

2,393 patent compounds predicted against PARL, 1,075 high-confidence (nearest known ligand ≥ 0.5)

Top predicted compounds (top 20 by supporting neighbours, then confidence)

CompoundConfidenceSupporting neighbours
SCHEMBL12339094 SCHEMBL12339094 0.81 5/20
SCHEMBL64964 SCHEMBL64964 1.00 4/20
SCHEMBL7973261 SCHEMBL7973261 1.00 4/20
SCHEMBL11402547 SCHEMBL11402547 1.00 4/20
SCHEMBL65876 SCHEMBL65876 0.86 4/20
SCHEMBL7973267 SCHEMBL7973267 0.65 4/20
SCHEMBL5367011 SCHEMBL5367011 0.62 4/20
SCHEMBL1606492 SCHEMBL1606492 0.59 4/20
SCHEMBL7161148 SCHEMBL7161148 0.58 4/20
SCHEMBL64963 SCHEMBL64963 0.53 4/20
SCHEMBL11765374 SCHEMBL11765374 0.52 4/20
SCHEMBL64814 SCHEMBL64814 0.50 4/20
SCHEMBL64828 SCHEMBL64828 0.50 4/20
SCHEMBL1702307 SCHEMBL1702307 0.50 4/20
SCHEMBL3087267 SCHEMBL3087267 0.50 4/20
Pyridine Pyridine (SCHEMBL9065176) 0.50 4/20
SCHEMBL812586 SCHEMBL812586 0.41 4/20
SCHEMBL11381247 SCHEMBL11381247 0.41 4/20
Succinchlorimide Succinchlorimide (SCHEMBL312793) 0.38 4/20
SCHEMBL313161 SCHEMBL313161 0.38 4/20

Clinical trials — most relevant to PARL by text similarity (a relevance ranking, not an exhaustive list)

TrialPhaseStatus
Dominantly Inherited Alzheimer Network Trial: An Opportunity to Prevent Dementia. A Study of Potential Disease Modifying Treatments in Individuals at Risk for or With a Type of Early Onset Alzheimer's Disease Caused by a Genetic Mutation. PHASE2/PHASE3COMPLETED
Dominantly Inherited Alzheimer Network Trial: An Opportunity to Prevent Dementia. A Study of Potential Disease Modifying Treatments in Individuals at Risk for or With a Type of Early Onset Alzheimer's Disease Caused by a Genetic Mutation. Master Protocol DIAN-TU-001 PHASE2/PHASE3ACTIVE_NOT_RECRUITING
Bridging Study of C11 Pittsburgh Compound B (PiB) and F18 Flutemetamol Brain Positron Emission Tomography (PET) PHASE2COMPLETED
Choline Effects - Pre-symptomatic AD PHASE1COMPLETED
Effects of Lithium Therapy on Blood-based Therapeutic Targets in Parkinson's Disease. PHASE1COMPLETED
Study of Biodistribution, Metabolism, Excretion and Brain Uptake 18F-JSS20-183A EARLY_PHASE1RECRUITING
Toward Molecular Profiling of Parkinson's Disease in Easily Accessible Biological Matrices nanACTIVE_NOT_RECRUITING
Consortium On Risk for Early-onset Parkinson's Disease (CORE PD) nanCOMPLETED
Blood-based Biomarkers for the Prognosis of Sports Related Concussion nanCOMPLETED
Biomarker Profiling in Individuals at Risk for Prion Disease nanRECRUITING
Parkinson's Diseases Susceptibility Genes and Pesticides nanCOMPLETED
Progression Follow up of the First-degree Relatives of Patients With REM Sleep Behavior Disorder nanUNKNOWN
Identification of New FTLD Genes nanUNKNOWN
Rostock International Parkinson's Disease Study (ROPAD) nanCOMPLETED
Late Onset Alzheimer's Disease nanRECRUITING
Parkinson's Foundation PD GENEration Genetic Registry nanRECRUITING
Genetic Characterization of Parkinson's Disease nanCOMPLETED
Parkinson's Families Project nanRECRUITING
Unstructured Eye Tracking as a Diagnostic and Prognostic Biomarker in Parkinsonian Disorders nanUNKNOWN
Thrombin Regulated Platelet Activation nanCOMPLETED
Implementation of Molecular Diagnostic Pathways nanUNKNOWN
PDGeneration: Mapping the Future of Parkinson's Disease nanUNKNOWN
Genetic Analysis of Hereditary Disorders of Hearing and Balance nanCOMPLETED
Cerebral Autosomal Dominant Arteriopathy With Subcortical Infarcts and Leukoencephalopathy (CADASIL) Study nanRECRUITING
The Genetic Characterization of Dementia nanCOMPLETED
Genes, Proteins, and Metabolites in Drug-resistant Epilepsy (DRE) Patients nanNOT_YET_RECRUITING
Diagnosis of RSTS: Identification of the Acetylation Profiles as Epigenetic Markers for Assessing Causality of CREBBP and EP300 Variants. nanUNKNOWN
Genetics of Rolandic Epilepsy nanCOMPLETED
China Cognition and Aging Study nanRECRUITING
Study of Comprehensive ANd Multimodal Marker-based Cohort of Progressive Supranuclear Palsy(PSP) nanUNKNOWN

Related proteins — ESM-2 sequence neighbours (a PARL binder may also engage these)

ProteinNameSimilarity
Q5R5H4 1.000 Q5R5H4 →
Q2KHV4 1.000 Q2KHV4 →
Q5XJY4 1.000 Q5XJY4 →
Q3B8P0 0.999 Q3B8P0 →
Q58EK4 0.955 Q58EK4 →
Q5R460 0.950 Q5R460 →
Q12887 0.945 Q12887 →
Q8CFY5 0.944 Q8CFY5 →
P09925 0.943 P09925 →
MCU Calcium uniporter protein, mitochondrial 0.943 landscape →
Q5SRD1 0.942 Q5SRD1 →
Q9QXU2 0.941 Q9QXU2 →
O14925 0.940 O14925 →
Q6P4H8 0.940 Q6P4H8 →
Q99KU0 0.940 Q99KU0 →
Q15526 0.939 Q15526 →
D3ZLY0 0.939 D3ZLY0 →
Q3UMR5 0.939 Q3UMR5 →
TIMM44 Mitochondrial import inner membrane translocase subunit TIM44 0.939 landscape →
Q5R9K4 0.939 Q5R9K4 →
Q6INE8 0.939 Q6INE8 →
Q9JI99 0.939 Q9JI99 →
Q8RXW0 0.939 Q8RXW0 →
O35093 0.939 O35093 →
Q6INU6 0.938 Q6INU6 →
Q9D1Z3 0.938 Q9D1Z3 →
Q0VCK9 0.938 Q0VCK9 →
Q5XH94 0.937 Q5XH94 →
Q9ERM3 0.937 Q9ERM3 →
Q68EQ9 0.937 Q68EQ9 →